GRAIL, Inc. (GRAL)
99.25
-5.59
(-5.33%)
USD |
NASDAQ |
Nov 20, 16:00
102.00
+2.75
(+2.77%)
After-Hours: 20:00
GRAIL Cash and Short Term Investments (Annual) : 904.43M for Dec. 31, 2025
Cash and Short Term Investments (Annual) Chart
Historical Cash and Short Term Investments (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 904.43M |
| December 31, 2024 | 763.47M |
| December 31, 2023 | 97.29M |
| December 31, 2022 | 241.60M |
| Date | Value |
|---|---|
| December 31, 2021 | |
| December 31, 2020 | |
| December 31, 2019 | 544.34M |
| December 31, 2018 | 641.35M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Annual) Benchmarks
| Moderna, Inc. | 5.80B |
| Twist Bioscience Corp. | 581.91M |
| Prime Medicine, Inc. | 177.68M |
| Kailera Therapeutics, Inc. | 546.06M |
| Oncolytics Biotech, Inc. | 5.202M |